2022•British Journal of HaematologyRequires access

Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma

Yawara Kawano, Hiroyuki Hata, Seiji Takashio, Kenichi Tsujita, Mitsuharu Ueda, Masao Matsuoka

Abstract

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Daratumumab, Medicine, AL amyloidosis, Lenalidomide, Multiple myeloma, Amyloidosis, Internal medicine, Primary systemic amyloidosis